Index RUT P/E - EPS (ttm) -0.11 Insider Own 5.07% Shs Outstand 185.72M Perf Week -8.33%
Market Cap 306.43M Forward P/E - EPS next Y -0.02 Insider Trans -1.23% Shs Float 176.31M Perf Month -8.84%
Income -20.92M PEG - EPS next Q -0.04 Inst Own 76.32% Short Float 4.88% Perf Quarter -1.20%
Sales 186.21M P/S 1.65 EPS this Y 14.55% Inst Trans -6.76% Short Ratio 6.46 Perf Half Y -24.31%
Book/sh 0.29 P/B 5.73 EPS next Y 80.85% ROA -10.49% Short Interest 8.60M Perf Year -28.57%
Cash/sh 0.43 P/C 3.81 EPS next 5Y - ROE -38.45% 52W Range 1.38 - 2.59 Perf YTD 7.14%
Dividend Est. - P/FCF - EPS past 5Y 25.97% ROI -15.77% 52W High -36.17% Beta 1.55
Dividend TTM - Quick Ratio 1.79 Sales past 5Y 22.11% Gross Margin 56.64% 52W Low 20.00% ATR (14) 0.12
Dividend Ex-Date - Current Ratio 2.39 EPS Y/Y TTM 45.45% Oper. Margin -15.75% RSI (14) 41.40 Volatility 7.85% 7.43%
Employees 288 Debt/Eq 1.75 Sales Y/Y TTM 19.09% Profit Margin -11.23% Recom 1.67 Target Price 3.90
Option/Short Yes / Yes LT Debt/Eq 1.36 EPS Q/Q -86.30% Payout - Rel Volume 2.59 Prev Close 1.74
Sales Surprise 4.35% EPS Surprise 16.67% Sales Q/Q 21.35% Earnings Feb 20 AMC Avg Volume 1.33M Price 1.65
SMA20 -10.47% SMA50 -5.85% SMA200 -11.92% Trades
Volume 3,455,302 Change -5.17%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-24 Initiated Craig Hallum
Buy
$5
Jan-20-23 Downgrade BTIG Research
Buy → Neutral
Jan-17-23 Downgrade Stephens
Overweight → Equal-Weight
$3.75
Oct-08-20 Resumed BTIG Research
Buy
$9
Jun-16-20 Resumed Cantor Fitzgerald
Overweight
$9
Feb-26-20 Initiated BTIG Research
Buy
$7
Nov-13-19 Upgrade BTIG Research
Neutral → Buy
$7
Aug-28-19 Initiated Stifel
Buy
Aug-23-19 Resumed Stephens
Overweight
Jan-05-18 Resumed Cantor Fitzgerald
Overweight
Dec-08-17 Resumed BTIG Research
Neutral
Jul-07-16 Resumed Cantor Fitzgerald
Buy
$9
Dec-17-15 Downgrade Wedbush
Outperform → Neutral
May-02-14 Reiterated MLV & Co
Buy
$8.50 → $6
Apr-24-13 Reiterated Cantor Fitzgerald
Buy
$5.50 → $6
Mar-15-13 Reiterated MLV & Co
Buy
$7.50 → $8.50
Apr-17-12 Initiated Cantor Fitzgerald
Buy
$5.50
Feb-29-12 Upgrade Robert W. Baird
Neutral → Outperform
$3 → $6
Nov-10-11 Reiterated MLV & Co
Buy
$4 → $5
Jun-03-11 Initiated Wedbush
Outperform
$4
Show Previous Ratings
Today 02:14AM
Feb-20-25 04:20PM
(Associated Press Finance)
04:00PM
09:27AM
Feb-19-25 04:00PM
08:30AM
Loading…
Feb-07-25 08:30AM
Jan-13-25 08:30AM
Nov-13-24 08:30AM
Oct-31-24 02:11PM
(Thomson Reuters StreetEvents) -8.72%
05:01AM
Oct-30-24 05:10PM
04:06PM
(Associated Press Finance)
04:00PM
Oct-29-24 09:16AM
Oct-18-24 08:30AM
08:30AM
Loading…
08:30AM
08:25AM
Oct-16-24 04:00PM
Oct-09-24 03:49PM
Sep-06-24 01:47AM
Aug-01-24 05:10PM
04:07PM
(Associated Press Finance)
04:00PM
Jul-18-24 08:30AM
Jul-02-24 04:00PM
Jun-21-24 08:30AM
Jun-14-24 08:30AM
May-22-24 08:30AM
May-03-24 10:40AM
06:48AM
(Thomson Reuters StreetEvents)
03:58AM
Loading…
03:58AM
May-02-24 08:59PM
06:04PM
04:04PM
(Associated Press Finance)
04:00PM
Apr-18-24 08:30AM
Mar-26-24 08:30AM
Mar-19-24 08:00AM
Mar-15-24 01:49AM
01:48AM
Mar-07-24 01:40PM
11:46AM
Mar-06-24 06:23AM
(Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM
04:26PM
(Associated Press Finance)
04:00PM
Feb-23-24 11:56AM
Feb-20-24 08:30AM
Feb-01-24 08:30AM
Jan-15-24 09:30AM
Jan-08-24 08:30AM
Nov-03-23 09:19AM
08:30AM
Nov-02-23 06:43PM
05:25PM
04:20PM
(Associated Press Finance)
04:00PM
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-31-23 12:36PM
Jul-19-23 08:30AM
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
04:10PM
04:00PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
04:00PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gregory Dean A. Director Dec 13 '24 Buy 1.70 1,725 2,932 61,725 Jan 02 05:46 PM BJERKHOLT ERIC Director Dec 12 '24 Sale 1.78 20,000 35,700 162,133 Dec 16 08:37 PM Jensen Chrystal Chief Legal Officer Dec 16 '24 Sale 1.71 16,667 28,501 457,578 Dec 16 08:34 PM CHRYSTAL NIKOLE JENSEN Officer Dec 16 '24 Proposed Sale 1.72 16,667 28,626 Dec 16 04:17 PM BJERKHOLT ERIC Director Dec 12 '24 Proposed Sale 1.78 20,000 35,700 Dec 12 04:41 PM Green Kevin Dennis Chief Financial Officer Sep 04 '24 Sale 2.15 54,272 116,826 536,093 Sep 05 05:05 PM Green Kevin Dennis Chief Financial Officer Sep 03 '24 Sale 2.18 28,385 61,919 590,365 Sep 05 05:05 PM KEVIN D GREEN Officer Sep 04 '24 Proposed Sale 2.15 54,272 116,826 Sep 04 04:14 PM KEVIN D GREEN Officer Sep 03 '24 Proposed Sale 2.18 28,385 61,919 Sep 03 04:28 PM Jensen Chrystal Chief Legal Officer Aug 15 '24 Sale 2.06 16,667 34,417 474,245 Aug 19 04:35 PM CHRYSTAL NIKOLE JENSEN Officer Aug 15 '24 Proposed Sale 2.07 16,667 34,427 Aug 15 04:41 PM Benjamin Richard J Chief Medical Officer Aug 02 '24 Sale 2.50 21,605 54,012 438,007 Aug 07 04:07 PM RICHARD J BENJAMIN Officer Aug 02 '24 Proposed Sale 2.50 21,605 54,012 Aug 02 04:09 PM Shan Hua Director May 13 '24 Buy 1.99 2,500 4,975 32,386 May 14 06:30 PM NACHTSHEIM JAMI K Director May 10 '24 Buy 1.79 2,000 3,578 108,362 May 13 05:09 PM Witney Frank Director May 09 '24 Buy 1.89 20,000 37,800 180,059 May 10 08:17 PM Swisher Daniel N JR Director May 09 '24 Buy 1.88 2,500 4,689 107,045 May 09 05:15 PM Green Kevin Dennis Chief Financial Officer Mar 14 '24 Sale 1.97 21,497 42,444 618,750 Mar 14 09:53 PM Green Kevin Dennis Chief Financial Officer Mar 13 '24 Sale 2.02 21,058 42,438 640,247 Mar 14 09:53 PM Moore Carol SVP Reg. & Quality Mar 13 '24 Sale 2.02 20,619 41,553 490,623 Mar 14 09:49 PM Jensen Chrystal Chief Legal Officer Mar 13 '24 Sale 2.06 17,460 35,915 508,736 Mar 14 09:47 PM Jensen Chrystal Chief Legal Officer Mar 14 '24 Sale 1.97 17,824 35,192 490,912 Mar 14 09:47 PM Jayaraman Vivek K Chief Operating Officer Mar 13 '24 Sale 2.06 26,247 53,990 905,447 Mar 14 09:33 PM Jayaraman Vivek K Chief Operating Officer Mar 14 '24 Sale 1.97 26,794 52,902 878,653 Mar 14 09:33 PM Greenman William Mariner President and CEO Mar 14 '24 Sale 2.02 63,611 128,195 3,181,281 Mar 14 09:30 PM Greenman William Mariner President and CEO Mar 13 '24 Sale 2.06 62,315 128,182 3,244,892 Mar 14 09:30 PM CORASH LAURENCE M Chief Scientific Officer Mar 13 '24 Sale 2.06 14,067 28,936 2,354,100 Mar 14 09:22 PM CORASH LAURENCE M Chief Scientific Officer Mar 14 '24 Sale 1.97 14,360 28,352 2,339,740 Mar 14 09:22 PM Benjamin Richard J Chief Medical Officer Mar 13 '24 Sale 2.06 17,377 35,744 477,350 Mar 14 09:15 PM Benjamin Richard J Chief Medical Officer Mar 14 '24 Sale 1.97 17,738 35,022 459,612 Mar 14 09:15 PM Benjamin Richard J Chief Medical Officer Mar 08 '24 Sale 2.40 29,378 70,457 478,061 Mar 12 06:10 PM
Index RUT P/E - EPS (ttm) -2.07 Insider Own 20.59% Shs Outstand 47.97M Perf Week 3.45%
Market Cap 2.52B Forward P/E - EPS next Y -0.59 Insider Trans -0.43% Shs Float 38.12M Perf Month 12.26%
Income -97.30M PEG - EPS next Q -0.26 Inst Own 93.61% Short Float 17.24% Perf Quarter 26.63%
Sales 307.03M P/S 8.20 EPS this Y 59.12% Inst Trans -1.81% Short Ratio 14.64 Perf Half Y 27.96%
Book/sh 4.84 P/B 10.84 EPS next Y 63.64% ROA -14.76% Short Interest 6.57M Perf Year 80.30%
Cash/sh 5.93 P/C 8.85 EPS next 5Y - ROE -38.83% 52W Range 23.14 - 53.76 Perf YTD 26.84%
Dividend Est. - P/FCF - EPS past 5Y -39.57% ROI -17.75% 52W High -2.43% Beta 1.04
Dividend TTM - Quick Ratio 3.15 Sales past 5Y 111.13% Gross Margin 73.31% 52W Low 126.66% ATR (14) 1.95
Dividend Ex-Date - Current Ratio 3.34 EPS Y/Y TTM 51.94% Oper. Margin -30.44% RSI (14) 64.07 Volatility 4.52% 3.85%
Employees 264 Debt/Eq 1.37 Sales Y/Y TTM 112.14% Profit Margin -31.69% Recom 1.10 Target Price 63.00
Option/Short Yes / Yes LT Debt/Eq 1.36 EPS Q/Q 48.09% Payout - Rel Volume 2.09 Prev Close 53.16
Sales Surprise 10.22% EPS Surprise 33.24% Sales Q/Q 89.37% Earnings Feb 26 AMC Avg Volume 448.86K Price 52.45
SMA20 4.23% SMA50 13.85% SMA200 33.16% Trades
Volume 940,040 Change -1.34%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Initiated Stifel
Buy
$48
Dec-18-23 Reiterated H.C. Wainwright
Buy
$60 → $58
Nov-20-23 Resumed JP Morgan
Overweight
$37
Nov-13-23 Initiated Morgan Stanley
Overweight
$60
Oct-24-23 Initiated Cantor Fitzgerald
Overweight
$50
Oct-17-23 Resumed Evercore ISI
Outperform
$62
Sep-20-23 Initiated JMP Securities
Mkt Outperform
$70
Sep-01-22 Initiated Citigroup
Buy
$38
Sep-20-21 Initiated JP Morgan
Overweight
$30
Aug-07-20 Upgrade Raymond James
Outperform → Strong Buy
$28 → $48
Aug-03-20 Initiated H.C. Wainwright
Buy
$52
Jul-31-20 Initiated Piper Sandler
Overweight
$77
Jun-25-20 Initiated Robert W. Baird
Outperform
$30
Aug-12-19 Initiated ROTH Capital
Buy
$33
Aug-12-19 Initiated Raymond James
Outperform
$28
Aug-12-19 Initiated Guggenheim
Buy
$18
Aug-12-19 Initiated Evercore ISI
Outperform
Aug-12-19 Initiated Citigroup
Buy
$21
Show Previous Ratings
Feb-19-25 04:04PM
Feb-10-25 07:00PM
Jan-24-25 12:00PM
Jan-14-25 08:50AM
Jan-13-25 08:30AM
06:30PM
Loading…
Jan-10-25 06:30PM
Jan-06-25 04:04PM
Dec-12-24 11:30AM
Dec-10-24 06:00PM
Dec-06-24 06:46AM
Nov-14-24 08:00AM
Nov-13-24 02:09AM
Nov-12-24 09:15AM
08:00AM
Nov-08-24 06:30PM
04:30PM
Loading…
Nov-07-24 04:30PM
Nov-04-24 04:30PM
Oct-31-24 10:02AM
08:30AM
Oct-23-24 08:49AM
Oct-10-24 07:30PM
08:30AM
Oct-09-24 05:18PM
Sep-10-24 08:45PM
Sep-06-24 01:31PM
(Investor's Business Daily)
11:31AM
Aug-28-24 04:01PM
Aug-19-24 11:06AM
Aug-09-24 07:00PM
Aug-08-24 11:01AM
05:25PM
Loading…
Aug-07-24 05:25PM
04:01PM
Jul-31-24 04:30PM
Jul-29-24 07:28AM
Jul-25-24 08:30AM
Jul-12-24 01:22PM
(Investor's Business Daily)
Jul-10-24 07:00PM
Jul-09-24 10:37AM
Jul-08-24 11:38AM
08:30AM
Jun-28-24 02:26PM
(Investor's Business Daily)
08:30AM
Jun-25-24 11:31AM
(Investor's Business Daily)
Jun-18-24 11:14AM
05:46AM
Jun-17-24 08:00AM
Jun-16-24 05:00PM
Jun-10-24 10:00PM
Jun-07-24 11:30AM
Jun-06-24 09:30AM
Jun-05-24 04:05PM
Jun-03-24 06:46AM
(Pharmaceutical Technology) +5.49%
May-31-24 08:30AM
May-29-24 08:30AM
May-28-24 10:02AM
May-18-24 07:00AM
May-13-24 09:40AM
May-10-24 07:30PM
01:55PM
01:12PM
May-09-24 11:46AM
07:40AM
(Thomson Reuters StreetEvents)
03:49AM
May-08-24 04:02PM
May-07-24 04:10PM
11:29AM
08:30AM
May-02-24 02:33PM
May-01-24 04:10PM
Apr-25-24 10:02AM
Apr-10-24 09:30PM
Apr-02-24 08:30AM
Mar-29-24 11:30AM
Mar-25-24 11:46PM
07:00AM
Mar-15-24 09:32AM
Mar-13-24 06:00PM
Mar-08-24 07:30PM
Mar-05-24 08:00AM
Feb-29-24 11:34AM
09:49AM
08:30AM
Feb-28-24 05:35PM
04:38PM
04:03PM
Feb-21-24 04:05PM
Feb-09-24 09:15PM
Feb-05-24 07:00AM
Jan-23-24 11:44AM
Jan-19-24 09:30PM
Jan-16-24 08:30AM
Jan-15-24 04:03AM
Jan-10-24 07:00PM
Jan-08-24 08:30AM
Jan-03-24 08:45AM
Dec-18-23 01:05PM
(Associated Press Finance) -15.87%
08:37AM
08:30AM
Dec-08-23 07:30PM
Nov-30-23 09:45AM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Radovich Peter PRESIDENT AND COO Feb 03 '25 Sale 48.22 2,627 126,681 26,961 Feb 04 05:30 PM Peetz Christopher CHIEF EXECUTIVE OFFICER Feb 03 '25 Sale 48.22 9,102 438,921 115,920 Feb 04 05:30 PM Howe Jolanda SVP, GLOBAL CONTROLLER Feb 03 '25 Sale 48.22 1,064 51,309 4,232 Feb 04 05:30 PM Radovich Peter PRESIDENT AND COO Jan 24 '25 Sale 47.92 3,177 152,256 29,588 Jan 27 04:50 PM Howe Jolanda SVP, GLOBAL CONTROLLER Jan 24 '25 Sale 47.92 902 43,228 3,524 Jan 27 04:48 PM Peetz Christopher CHIEF EXECUTIVE OFFICER Jan 24 '25 Sale 47.92 6,837 327,658 125,022 Jan 27 04:48 PM Quan Joanne CHIEF MEDICAL OFFICER Jan 17 '25 Sale 45.86 6,969 319,598 5,649 Jan 21 04:21 PM Radovich Peter PRESIDENT AND COO Jan 07 '25 Sale 42.82 1,998 85,545 27,015 Jan 08 04:44 PM Peetz Christopher CHIEF EXECUTIVE OFFICER Jan 07 '25 Sale 42.82 7,489 320,644 119,359 Jan 08 04:42 PM Howe Jolanda SVP, GLOBAL CONTROLLER Jan 07 '25 Sale 42.82 750 32,111 2,926 Jan 08 04:38 PM Howe Jolanda SVP, GLOBAL CONTROLLER Nov 14 '24 Option Exercise 2.94 2,500 7,350 4,926 Nov 15 05:34 PM Howe Jolanda SVP, GLOBAL CONTROLLER Nov 14 '24 Sale 47.10 2,500 117,752 2,426 Nov 15 05:34 PM Heron Patrick J Director Sep 18 '24 Buy 37.40 115 4,301 162,308 Sep 20 04:39 PM Heron Patrick J Director Sep 06 '24 Buy 41.58 230 9,563 162,193 Sep 10 05:04 PM Peetz Christopher CHIEF EXECUTIVE OFFICER Jul 23 '24 Option Exercise 2.94 34,013 99,862 126,783 Jul 24 05:32 PM Howe Jolanda SVP, GLOBAL CONTROLLER Jul 02 '24 Sale 34.00 375 12,750 2,426 Jul 03 06:19 PM Vig Pamela CHIEF SCIENTIFIC OFFICER Jun 24 '24 Option Exercise 2.94 30,559 89,721 57,965 Jun 25 05:15 PM Vig Pamela CHIEF SCIENTIFIC OFFICER Jun 24 '24 Sale 34.00 30,559 1,039,006 27,406 Jun 25 05:15 PM Ramasastry Saira Director Jun 05 '24 Option Exercise 14.12 5,000 70,600 5,000 Jun 07 06:20 PM Ramasastry Saira Director Jun 05 '24 Sale 25.68 5,000 128,400 0 Jun 07 06:20 PM BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Mar 27 '24 Buy 24.80 2,000 49,600 14,000 Mar 27 08:47 PM Radovich Peter PRESIDENT AND COO Mar 25 '24 Sale 25.80 4,303 111,017 29,013 Mar 25 05:41 PM BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Mar 18 '24 Buy 25.80 2,000 51,600 12,000 Mar 18 05:34 PM
Index - P/E - EPS (ttm) -1.57 Insider Own 48.65% Shs Outstand 10.76M Perf Week -11.99%
Market Cap 31.69M Forward P/E - EPS next Y -0.79 Insider Trans 6.35% Shs Float 6.92M Perf Month -20.07%
Income -13.59M PEG - EPS next Q -0.42 Inst Own 24.86% Short Float 1.00% Perf Quarter -30.47%
Sales 0.00M P/S - EPS this Y 80.87% Inst Trans 24.40% Short Ratio 1.62 Perf Half Y -38.96%
Book/sh 0.84 P/B 2.80 EPS next Y 46.08% ROA -84.77% Short Interest 0.07M Perf Year -47.66%
Cash/sh 1.08 P/C 2.17 EPS next 5Y 38.52% ROE -128.26% 52W Range 2.05 - 6.26 Perf YTD -33.62%
Dividend Est. - P/FCF - EPS past 5Y 19.56% ROI -150.48% 52W High -62.49% Beta 1.15
Dividend TTM - Quick Ratio 4.15 Sales past 5Y 0.00% Gross Margin - 52W Low 14.63% ATR (14) 0.25
Dividend Ex-Date - Current Ratio 4.15 EPS Y/Y TTM 94.80% Oper. Margin - RSI (14) 35.05 Volatility 10.37% 9.72%
Employees 14 Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 14.00
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q 38.10% Payout - Rel Volume 0.36 Prev Close 2.44
Sales Surprise - EPS Surprise 11.11% Sales Q/Q - Earnings Nov 13 BMO Avg Volume 42.69K Price 2.35
SMA20 -9.39% SMA50 -16.65% SMA200 -41.19% Trades
Volume 15,497 Change -3.69%
Feb-19-25 07:00AM
Feb-03-25 04:05PM
Jan-14-25 07:00AM
Nov-21-24 08:00AM
Nov-20-24 04:05PM
07:00AM
Loading…
Nov-13-24 07:00AM
Nov-07-24 07:00AM
Oct-30-24 10:11PM
(PR Newswire) +22.14%
-22.92%
04:50PM
07:00AM
Oct-28-24 04:05PM
Oct-16-24 08:00AM
Sep-03-24 08:00AM
Aug-12-24 04:10PM
Jul-09-24 07:30AM
08:00AM
Loading…
Jul-08-24 08:00AM
Jul-01-24 08:00AM
Jun-27-24 08:00AM
07:06AM
Jun-26-24 04:05PM
May-28-24 07:53AM
May-21-24 09:48AM
May-13-24 04:05PM
(PR Newswire) -7.14%
+6.73%
May-07-24 08:00AM
Apr-24-24 08:00AM
Apr-10-24 03:30PM
Mar-28-24 11:53AM
07:00AM
Mar-13-24 08:00AM
Feb-28-24 06:57PM
08:00AM
Loading…
Feb-13-24 08:00AM
Feb-07-24 04:05PM
(PR Newswire) +6.92%
-9.99%
Jan-22-24 08:00AM
Dec-11-23 07:30AM
Nov-09-23 07:00AM
Nov-02-23 09:15AM
Sep-06-23 07:30AM
Aug-31-23 07:30AM
Aug-11-23 07:01AM
Aug-10-23 04:05PM
06:24AM
Aug-09-23 07:30AM
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-12-23 07:30AM
Jun-06-23 07:30AM
May-23-23 07:30AM
May-15-23 08:55AM
Mar-29-23 07:53PM
(TipRanks) -8.76%
-29.60%
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MIDDLETON FRED A Director Dec 06 '24 Buy 2.65 4,800 12,720 36,514 Dec 06 07:12 PM Sanderling Venture Partners VI 10% Owner Nov 01 '24 Buy 3.75 86,867 325,751 814,300 Nov 05 03:08 PM Sanderling Venture Partners VI 10% Owner Nov 01 '24 Buy 3.75 877 3,289 22,479 Nov 05 03:08 PM MIDDLETON FRED A Director Nov 01 '24 Buy 3.75 87,744 329,040 814,300 Nov 05 03:04 PM MIDDLETON FRED A Director Nov 01 '24 Buy 3.75 20,000 75,000 31,714 Nov 05 03:04 PM Leheny A. Rachel CHIEF EXECUTIVE OFFICER Nov 01 '24 Buy 3.75 20,000 75,000 130,926 Nov 01 01:25 PM Roberts Eric W CHIEF BUSINESS OFFICER Nov 01 '24 Buy 3.75 53,333 199,999 164,706 Nov 01 01:24 PM WILSON ROBERT N Director Nov 01 '24 Buy 3.75 53,333 199,999 417,529 Nov 01 01:22 PM Dunn Michael J. President and COO Sep 09 '24 Option Exercise 1.39 11,761 16,348 11,761 Sep 11 05:00 PM Leheny A. Rachel CHIEF EXECUTIVE OFFICER Aug 27 '24 Buy 4.19 1,000 4,190 110,926 Aug 27 07:44 PM Roberts Eric W CHIEF BUSINESS OFFICER Aug 23 '24 Buy 3.57 5,000 17,867 46,894 Aug 26 06:00 PM WILSON ROBERT N Director Aug 23 '24 Buy 3.72 54,000 200,826 364,196 Aug 26 05:57 PM Roberts Eric W CHIEF BUSINESS OFFICER Aug 21 '24 Buy 4.04 5,000 20,200 44,894 Aug 22 06:02 PM WILSON ROBERT N Director Jun 28 '24 Buy 3.52 51,278 180,499 310,196 Jul 02 04:50 PM WILSON ROBERT N Director Jun 27 '24 Buy 3.23 8,443 27,305 258,918 Jul 01 03:12 PM Roberts Eric W CHIEF BUSINESS OFFICER Jun 27 '24 Buy 3.22 5,000 16,100 10,223 Jun 28 06:52 PM Roberts Eric W CHIEF BUSINESS OFFICER Apr 02 '24 Buy 3.90 3,254 12,691 39,894 Apr 02 08:33 PM Roberts Eric W CHIEF BUSINESS OFFICER Apr 01 '24 Buy 3.90 746 2,909 36,640 Apr 02 08:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
